Pharmagreen Biotech says it’s no longer under Chapter 11 proceedings after a stay order was lifted by a federal judge of the United States District Court for the Southern District of New York, on an action filed by EMA Financial LLC.
- Company does not plan to appeal this ruling
- CEO
Peter Wojcik says in statement that “We are committed to moving forward with the development of our business as planned” - NOTE: In August,
Pharmagreen Biotech Files for Chapter 11 in Nevada Court
To view the source of this information click
To contact the reporter on this story:
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.